Literature DB >> 9614026

Treatment of gastro-oesophageal reflux disease in adults.

J P Galmiche1, E Letessier, C Scarpignato.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9614026      PMCID： PMC1113276          DOI： 10.1136/bmj.316.7146.1720

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  37 in total

Review 1.  Tolerance during dosing with H2-receptor antagonists. An overview.

Authors:  C H Wilder-Smith; H S Merki
Journal:  Scand J Gastroenterol Suppl       Date:  1992

2.  Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisapride.

Authors:  J P Galmiche; P Barthelemy; B Hamelin
Journal:  Aliment Pharmacol Ther       Date:  1997-08       Impact factor: 8.171

Review 3.  Rationale and efficacy of conservative therapy for gastroesophageal reflux disease.

Authors:  L I Kitchin; D O Castell
Journal:  Arch Intern Med       Date:  1991-03

4.  Why do apparently healthy people use antacid tablets?

Authors:  D Y Graham; J L Smith; D J Patterson
Journal:  Am J Gastroenterol       Date:  1983-05       Impact factor: 10.864

5.  Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. The Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group.

Authors:  S J Spechler
Journal:  N Engl J Med       Date:  1992-03-19       Impact factor: 91.245

Review 6.  Epidemiology and natural history of gastro-oesophageal reflux disease.

Authors:  S J Spechler
Journal:  Digestion       Date:  1992       Impact factor: 3.216

7.  Effect of cisapride on relapse of esophagitis. A multinational, placebo-controlled trial in patients healed with an antisecretory drug. The Italian Eurocis Trialists.

Authors:  A L Blum; B Adami; M H Bouzo; G Brandstätter; I Fumagalli; J P Galmiche; H Hebbeln; E Hentschel; W Hüttemann; E SChütz
Journal:  Dig Dis Sci       Date:  1993-03       Impact factor: 3.199

8.  Effects of sleeping with the bed-head raised and of ranitidine in patients with severe peptic oesophagitis.

Authors:  R F Harvey; P C Gordon; N Hadley; D E Long; T R Gill; R I Macpherson; B C Beats; A J Tottle
Journal:  Lancet       Date:  1987-11-21       Impact factor: 79.321

9.  Most asthmatics have gastroesophageal reflux with or without bronchodilator therapy.

Authors:  S J Sontag; S O'Connell; S Khandelwal; T Miller; B Nemchausky; T G Schnell; R Serlovsky
Journal:  Gastroenterology       Date:  1990-09       Impact factor: 22.682

10.  Dose--response effect of famotidine on patterns of gastro-oesophageal reflux.

Authors:  W C Orr; M G Robinson; T J Humphries; J Antonello; A Cagliola
Journal:  Aliment Pharmacol Ther       Date:  1988-06       Impact factor: 8.171
View more
  18 in total

Review 1.  Management of gastro-oesophageal reflux disease in general practice.

Authors:  J Dent; R Jones; P Kahrilas; N J Talley
Journal:  BMJ       Date:  2001-02-10

Review 2.  Endoscopy-negative reflux disease.

Authors:  J P Galmiche; S B des Varannes
Journal:  Curr Gastroenterol Rep       Date:  2001-06

3.  Intravenous esomeprazole.

Authors:  Gillian M Keating; David P Figgitt
Journal:  Drugs       Date:  2004       Impact factor: 9.546

4.  The Stretta procedure versus proton pump inhibitors and laparoscopic Nissen fundoplication in the management of gastroesophageal reflux disease: a cost-effectiveness analysis.

Authors:  Dan Comay; Viviane Adam; Ediardo B da Silveira; Wendy Kennedy; Serge Mayrand; Alan N Barkun
Journal:  Can J Gastroenterol       Date:  2008-06       Impact factor: 3.522

Review 5.  [Functional endoscopy : the physiological and pathophysiological basis of reflux disease, diagnosis and therapy].

Authors:  I F Herrmann; C Scarpignato
Journal:  HNO       Date:  2009-12       Impact factor: 1.284

6.  Treatment of gastro-oesophageal reflux disease in adults. Efficacy of surgery needs to be compared with that of proton pump inhibitors.

Authors:  O Chassany; J F Bergmann; C Caulin
Journal:  BMJ       Date:  1999-01-02

Review 7.  Pantoprazole: an update of its pharmacological properties and therapeutic use in the management of acid-related disorders.

Authors:  Susan M Cheer; Amitabh Prakash; Diana Faulds; Harriet M Lamb
Journal:  Drugs       Date:  2003       Impact factor: 9.546

8.  Treatment of GORD: Three decades of progress and disappointments.

Authors:  Jean Paul Galmiche; Frank Zerbib; Stanislas Bruley des Varannes
Journal:  United European Gastroenterol J       Date:  2013-06       Impact factor: 4.623

9.  Higher Esophageal Symptom Burden in Obese Subjects Results From Increased Esophageal Acid Exposure and Not From Dysmotility.

Authors:  Benjamin D Rogers; Amit Patel; Dan Wang; Gregory S Sayuk; C Prakash Gyawali
Journal:  Clin Gastroenterol Hepatol       Date:  2019-08-20       Impact factor: 11.382

10.  Impact of PPIs on patient focused symptomatology in GERD.

Authors:  Abr Thomson
Journal:  Ther Clin Risk Manag       Date:  2008-12       Impact factor: 2.423
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.